Skip to main content

Dr. Janet Pope: JAK 2 Inhibitor Controversy

Nov 07, 2017 1:31 am
Dr. Janet Pope talks about JAK 2 inhibitors and increased VTE as presented at the ACR/ARHP Annual Meeting in San Diego.

Add new comment

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×